Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1016/j.tvjl.2007.07.003. Epub 2007 Aug 24.
Affiliations
- PMID: 17719811
- DOI: 10.1016/j.tvjl.2007.07.003
Randomized Controlled Trial
Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies
Katie E Asplin et al. Vet J. 2007 Nov.
Abstract
The purpose of this study was to determine the effects of prolonged administration of insulin, whilst maintaining normal glucose concentrations, on hoof lamellar integrity in vivo on healthy ponies with no known history of laminitis or insulin resistance. Nine clinically healthy, unrelated ponies were randomly allocated to either a treatment group (n =5; 5.9+/-1.7 years) or control group (n =4; 7.0+/-2.8 years). The treatment group received insulin via a euglycaemic hyperinsulinaemic clamp technique modified and prolonged for up to 72 h. Control ponies were infused with an equivalent volume of 0.9% saline. Ponies were euthanized at the Obel grade 2 stage of clinical laminitis and hoof lamellar tissues were harvested and examined for histopathological evidence of laminitis. Basal serum insulin and blood glucose concentrations were 15.7+/-1.8 microU/mL and 5.2+/-0.1 mmol/L, respectively (mean+/-SE) and were not significantly different between groups. Mean serum insulin concentration in treatment ponies was 1036+/-55 microU/mL vs. 14.6 microU/mL in controls. All ponies in the treatment group developed clinical and histological laminitis (Obel grade 2) in all four feet within 72 h (55.4+/-5.5h), whereas none of the control ponies developed laminitis. There was no clinical evidence of gastrointestinal involvement and the ponies showed no signs of systemic illness throughout the experiment. The data show that laminitis can be induced in healthy young ponies, with no prior history of laminitis, by maintaining prolonged hyperinsulinaemia with euglycaemia. This suggests a role for insulin in the pathogenesis of laminitis, independent of hyperglycaemia, or alterations in hind-gut fermentation. For the clinician, early detection and control of hyperinsulinaemia may facilitate management of endocrinopathic laminitis.
Similar articles
- Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.
de Laat MA, McGowan CM, Sillence MN, Pollitt CC. de Laat MA, et al. Equine Vet J. 2010 Mar;42(2):129-35. doi: 10.2746/042516409X475779. Equine Vet J. 2010. PMID: 20156248 Clinical Trial. - Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses.
de Laat MA, Sillence MN, McGowan CM, Pollitt CC. de Laat MA, et al. Vet J. 2012 Mar;191(3):317-22. doi: 10.1016/j.tvjl.2011.07.007. Epub 2011 Aug 27. Vet J. 2012. PMID: 21873088 - Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia.
Nourian AR, Asplin KE, McGowan CM, Sillence MN, Pollitt CC. Nourian AR, et al. Equine Vet J. 2009 Sep;41(7):671-7. doi: 10.2746/042516409x407648. Equine Vet J. 2009. PMID: 19927586 - Hyperinsulinemic laminitis.
de Laat MA, McGowan CM, Sillence MN, Pollitt CC. de Laat MA, et al. Vet Clin North Am Equine Pract. 2010 Aug;26(2):257-64. doi: 10.1016/j.cveq.2010.04.003. Epub 2010 Jun 8. Vet Clin North Am Equine Pract. 2010. PMID: 20699173 Review. - Field treatment and management of endocrinopathic laminitis in horses and ponies.
Walsh DM. Walsh DM. Vet Clin North Am Equine Pract. 2010 Aug;26(2):379-90. doi: 10.1016/j.cveq.2010.05.001. Vet Clin North Am Equine Pract. 2010. PMID: 20699182 Review.
Cited by
- Metabolic and Endocrine Insights in Donkeys.
Mendoza FJ, Toribio RE, Perez-Ecija A. Mendoza FJ, et al. Animals (Basel). 2024 Feb 10;14(4):590. doi: 10.3390/ani14040590. Animals (Basel). 2024. PMID: 38396558 Free PMC article. Review. - Effect of 5'-adenosine monophosphate-activated protein kinase agonists on insulin and glucose dynamics in experimentally induced insulin dysregulation in horses.
Pinnell EF, Hostnik LD, Watts MR, Timko KJ, Thriffiley AA, Stover MR, Koenig LE, Gorman OM, Toribio RE, Burns TA. Pinnell EF, et al. J Vet Intern Med. 2024 Jan-Feb;38(1):102-110. doi: 10.1111/jvim.16970. Epub 2023 Dec 13. J Vet Intern Med. 2024. PMID: 38088223 Free PMC article. - A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies.
de Laat MA, Fitzgerald DM, Harris PA, Bailey SR. de Laat MA, et al. J Anim Sci. 2023 Jan 3;101:skad389. doi: 10.1093/jas/skad389. J Anim Sci. 2023. PMID: 38066683 Free PMC article. - Development of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses.
Delarocque J, Feige K, Carslake HB, Durham AE, Fey K, Warnken T. Delarocque J, et al. Animals (Basel). 2023 Aug 24;13(17):2704. doi: 10.3390/ani13172704. Animals (Basel). 2023. PMID: 37684968 Free PMC article. - Equine Metabolic Syndrome: A Complex Disease Influenced by Multifactorial Genetic Factors.
Stefaniuk-Szmukier M, Piórkowska K, Ropka-Molik K. Stefaniuk-Szmukier M, et al. Genes (Basel). 2023 Jul 27;14(8):1544. doi: 10.3390/genes14081544. Genes (Basel). 2023. PMID: 37628596 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical